Meme Supposedly Itemizes 'The Trump-Vance Project 2025 Plan'
A meme purports to outline what it calls "The Trump-Vance Project 2025 Plan," although both U.S. President-elect Trump and ...
4DMT Reports Third Quarter 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones
Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting ...
Armed robbery in Revesby5d
Somalia: One Health Community Engagement Initiative
Farah Isse Mumin is a PhD student at the University of Liverpool and a research fellow at the International Livestock ...
Our Annual Under-$50 Gift Guide Is Here!
Looking for the best cheap gift ideas? Our expert picks are $50 and under. From a desktop vacuum to chic notebooks, your ...
The suburb where I grew up was dubbed ‘the ghetto’. I didn’t tell friends where I lived
Our feelings about the family home we grew up in can be complicated. For me, it’s joy, embarrassment and grief all at once.
Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update
Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ in rare pediatric disease HLHS has achieved more than 80% enrollmentPositive Type C ...
People Send Death Threats When They Find Out About My Dog Meat Farm. Here's What They're Missing.
"The message of Elwood’s Organic Dog Meat has traveled far and wide. Within a month of our website going up, the 'farm' went ...
manilatimes2d
HOOKIPA Pharma's Eseba-vec Highlighted in SITC Late-Breaker
The late-breaking poster: Eseba-vec (HB-200) plus pembrolizumab as first-line treatment of recurrent/metastatic ...
At the campaign finish line in Springfield, the city that became an accidental main character
In an instant, the Ohio city was transformed from a real place full of real people – with real problems, though not of the ...
manilatimes2d
Beyond Air® Reports Fiscal Second Quarter 2025 Financial Results and Provides Corporate Update
Beyond Air, Inc. (NASDAQ: XAIR) ("Beyond Air” or the "Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the ...
ADC Therapeutics Reports Third Quarter And Year-To-Date 2024 Financial Results And Provides Operational Update
LOTIS-5 full enrollment and LOTIS-7 initial efficacy, safety update anticipated by end of 2024 Updated ZYNLONTA® Phase 2 ...
The Globe and Mail5d
Century Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Updates
This builds upon earlier alignment with the U.S. Food and Drug Administration to expand clinical ... with four arms designed to evaluate the safety and preliminary efficacy of CNTY-101. The study will ...